Previously, various clinical prediction models, such as GALAD (Johnson et al., 2014) and ASAP (Yang et al., 2019), have been employed for liver cancer discrimination and diagnosis, with AFP playing a crucial role despite their excellent performance. Here, AFP is linked to liver cancer.